Key result
Study evaluates cardiac troponin-I stability in whole blood and plasma during acute MI.
Why the study?
The short-term stability and variability of cardiac troponin I in different blood sample types in patients with myocardial infarction were not well characterized.
Key points are not available for this paper at this time.
Comparison
EDTA whole blood vs heparinized whole blood vs EDTA plasma
Design
Observational study assessing repeatability and stability of cTnI measurements
Follow-up
48 hours
Provides preliminary troponin-I stability data in AMI; leaves open need for standardized handling protocols.
Introduction: In this study, we aimed to investigate the short-term stability and variability of cardiac troponin T (cTnI) in ethylenediamine tetraacetic acid (EDTA) whole blood, heparinized whole blood, and EDTA plasma. Methods: Thirteen patients with myocardial infarction were included. Venous blood samples (24 mL) from all patients were collected into vacuum tubes with EDTA and heparin (Becton Dickinson-USA), and analyses were performed on four different groups (one group for repeatability and three groups for stability). Results: There was no statistically significant difference in cTnI concentrations at baseline, 2, 4, 6, 12, 24, and 48 hours between the heparinized whole blood, EDTA whole blood, and EDTA plasma groups (group 2) (p>0.05). In the heparinized whole blood and EDTA plasma groups, there was a statistically significant difference between cTnI concentrations at baseline, 2, 4, 6, 12, 24, and 48 hours. In the EDTA whole blood group, there was no statistically significant difference between any time points. Conclusion: The interclass and intraclass correlation coefficients of the EDTA whole blood group were sufficiently high, which indicates better stability. EDTA whole blood samples are preferable for cTnI measurement because they are stable for 48 hours. EDTA-containing tubes are easy to find in clinical laboratories and do not need to be centrifuged, which saves time and effort.
No takes yet. Share an insight, caveat, or question.
Karabulut et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: